Minimal essential data to document contact tracing and single dose rifampicin (SDR) for leprosy control in routine settings: a practical guide
Richardus J, Kasang C, Mieras L, Anand S, Bonenberger M, Ignotti E, et al.. Leprosy review. 2018; 89(1):2-12.
Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.
Tiwari A, Dandel S, Djupuri R, Mieras L, Richardus J. BMC infectious diseases. 2018; 18(1):324.
The development of a mobile application to support peripheral health workers to diagnose and treat people with skin diseases in resource-poor settings.
Mieras L, Taal A, Post E, Ndeve A, van Hees C. Tropical medicine and infectious disease. 2018; 3(3):102.
A single dose of rifampicin to prevent leprosy: qualitative analysis of perceptions of people affected, contacts, community members and health professionals towards chemoprophylaxis and the impact on their attitudes in India, Nepal and Indonesia
Peters R, Mieras L, Subedi M, Apte H, Koesbardiati T, Banstola N, et al.. Leprosy review. 2018; 89(4):335-352.
The impact of leprosy on marital and sexual relationships of married Nepali men.
Meis MJ, Mieras L, Essink DR, Bastola N, van Brakel WH, Dhakal KP. Leprosy review. 2016;
Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
Mieras L, Anthony R, van Brakel WH, Bratschi MW, Van Den Broek J, Cambau E, et al.. Infectious diseases of poverty. 2016; 5(1):46.
Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel WH, Richardus J, Tiwari A, et al.. BMJ open. 2016; 6(11):e013633.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.